• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Cardiovascular Complications of Novel Multiple Myeloma Treatments.

作者信息

Li Weijuan, Cornell R Frank, Lenihan Daniel, Slosky David, Jagasia Madan, Piazza Gregory, Moslehi Javid

机构信息

From Department of Medicine, Jacobi Medical Center, Albert Einstein College of Medicine, New York, NY(W.L.); Division of Hematology and Oncology, Department of Internal Medicine, Vanderbilt University Medical Center, Nashville, TN(R.F.C., M.J., J.M.), Cardiovascular Division(D.L., D.S., J.M.) and Cardio-Oncology Program(D.L., D.S., J.M.), Vanderbilt University School of Medicine, Nashville, TN; and Division of Cardiovascular Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA(G.P.).

出版信息

Circulation. 2016 Mar 1;133(9):908-12. doi: 10.1161/CIRCULATIONAHA.115.018351.

DOI:10.1161/CIRCULATIONAHA.115.018351
PMID:26927008
Abstract
摘要

相似文献

1
Cardiovascular Complications of Novel Multiple Myeloma Treatments.新型多发性骨髓瘤治疗的心血管并发症
Circulation. 2016 Mar 1;133(9):908-12. doi: 10.1161/CIRCULATIONAHA.115.018351.
2
Maintenance therapy in multiple myeloma.
Clin Adv Hematol Oncol. 2014 Feb;12(2):133-4.
3
Efficacy and safety of thalidomide in the treatment of multiple myeloma.
Acta Pol Pharm. 2008 Nov-Dec;65(6):771-4.
4
Novel agents in first-line therapy for myeloma.
Oncology (Williston Park). 2005 Nov;19(12):1551-4.
5
Tumor lysis syndrome following thalidomide and dexamethasone therapy for newly diagnosed multiple myeloma.沙利度胺和地塞米松治疗新诊断多发性骨髓瘤后的肿瘤溶解综合征
Exp Hematol. 2006 Dec;34(12):1616. doi: 10.1016/j.exphem.2006.07.010.
6
Health-related quality of life in patients with multiple myeloma--does it matter?多发性骨髓瘤患者的健康相关生活质量——重要吗？
Haematologica. 2015 Jun;100(6):704-5. doi: 10.3324/haematol.2015.127860.
7
Optimising bortezomib in newly diagnosed multiple myeloma.优化硼替佐米用于新诊断的多发性骨髓瘤的治疗
Lancet Oncol. 2010 Oct;11(10):909-10. doi: 10.1016/S1470-2045(10)70199-6. Epub 2010 Aug 23.
8
Treatment options and considerations for the newly diagnosed myeloma patient.
Oncology (Williston Park). 2005 Sep;19(10):1260, 1262, 1267 passim.
9
Prevention of venous thromboembolism with low molecular-weight heparin in patients with multiple myeloma treated with thalidomide and chemotherapy.在接受沙利度胺和化疗的多发性骨髓瘤患者中使用低分子量肝素预防静脉血栓栓塞
Leukemia. 2004 Dec;18(12):2044-6. doi: 10.1038/sj.leu.2403533.
10
[Multiple myeloma: evaluation of invasiveness by magnetic resonance imaging].
Ter Arkh. 2010;82(4):64-7.

引用本文的文献

1
Cardio-Oncology and Multi-Imaging Modalities.心脏肿瘤学与多种成像模态
J Clin Med. 2025 Jun 18;14(12):4353. doi: 10.3390/jcm14124353.
2
Major cardiovascular events in long-term multiple myeloma survivors: a Korean case-control study (the CAREMM-2105 study).长期多发性骨髓瘤幸存者的主要心血管事件：一项韩国病例对照研究（CAREMM-2105 研究）。
Clin Exp Med. 2024 Jun 12;24(1):125. doi: 10.1007/s10238-024-01368-2.
3
Competing risk analysis of cardiovascular mortality in multiple myeloma survivors.多发性骨髓瘤幸存者心血管死亡率的竞争风险分析。
Transl Cancer Res. 2023 Dec 31;12(12):3314-3326. doi: 10.21037/tcr-23-1213. Epub 2023 Dec 12.
4
Patient-Related Factors Predicting Stent Thrombosis in Percutaneous Coronary Interventions.经皮冠状动脉介入治疗中预测支架血栓形成的患者相关因素。
J Clin Med. 2023 Nov 28;12(23):7367. doi: 10.3390/jcm12237367.
5
Prediction of cardiovascular adverse events in newly diagnosed multiple myeloma: Development and validation of a risk score prognostic model.新诊断多发性骨髓瘤患者心血管不良事件的预测：风险评分预后模型的建立与验证
Front Oncol. 2023 Mar 21;13:1043869. doi: 10.3389/fonc.2023.1043869. eCollection 2023.
6
High-Throughput Assessment of Real-World Medication Effects on QT Interval Prolongation: Observational Study.真实世界中药物对QT间期延长影响的高通量评估：观察性研究
JMIR Cardio. 2023 Jan 20;7:e41055. doi: 10.2196/41055.
7
Management of Acute Coronary Syndrome in Cancer Patients: It's High Time We Dealt with It.癌症患者急性冠状动脉综合征的管理：我们早该着手应对了。
J Clin Med. 2022 Mar 24;11(7):1792. doi: 10.3390/jcm11071792.
8
Bortezomib-Induced Reversible Cardiomyopathy: Recovered With Guideline-Directed Medical Therapy.硼替佐米诱导的可逆性心肌病：经指南指导的药物治疗后康复
Cureus. 2021 Dec 9;13(12):e20295. doi: 10.7759/cureus.20295. eCollection 2021 Dec.
9
Incidence of Arrhythmias and Their Prognostic Value in Patients With Multiple Myeloma.多发性骨髓瘤患者心律失常的发生率及其预后价值
Front Cardiovasc Med. 2021 Nov 15;8:753918. doi: 10.3389/fcvm.2021.753918. eCollection 2021.
10
Vascular Impact of Cancer Therapies: The Case of BTK (Bruton Tyrosine Kinase) Inhibitors.癌症治疗的血管影响：以 BTK（布鲁顿酪氨酸激酶）抑制剂为例。
Circ Res. 2021 Jun 11;128(12):1973-1987. doi: 10.1161/CIRCRESAHA.121.318259. Epub 2021 Jun 10.